Minerva Neurosciences | Nettoeinkommen





Nettoeinkommen Veränderung Datum
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Adma Biologics USD 36.43M 2.21M 2025-09
ALKERMES USD 49.34M 33.42M 2025-12
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
AstraZeneca USD 2.33B 207M 2025-12
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cipla INR 6.76B 6.75B 2025-12
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -6.98M 360K 2025-09
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 148.4M 15.76M 2025-09
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Novavax USD -121.3M 283.68M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12


Minerva Neurosciences Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.